Search

252 Result(s)
Sort by

survodutide top-line results MASH fibrosis

survodutide top-line results MASH fibrosis

Survodutide Phase II trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis
EMPERIAL-heart-failure-toplineresults

EMPERIAL-heart-failure-toplineresults

Update on the EMPERIAL-Reduced and EMPERIAL-Preserved studies, which assess exercise ability in adults with chronic heart failure with reduced and preserved ejection fraction
Partnering for innovation in animal health

Partnering for innovation in animal health

Collaboration with external partners is a fundamental part of our innovation strategy in Animal Health. Learn more about the partners we are looking for.
Aftopor®/Aftovaxpur®/Aftovax®

Aftopor®/Aftovaxpur®/Aftovax®

FMD vaccines with highly potent and purified antigens (Aftopor®, Aftovaxpur®) allow differentiation between infected and vaccinated animals for endemic or emergency situations.
Honey and Cinnamon Cookies video

Honey and Cinnamon Cookies video

Find out how to make these simple and sweet honey and cinnamon cookies from Taking Cancer On Through Flavour
Difficulties Chewing and Swallowing

Difficulties Chewing and Swallowing

Discover tips on how to overcome difficulties in chewing and swallowing food from Taking Cancer On Through Flavour
Rainbow Pizza Video

Rainbow Pizza Video

Find out how this rainbow pizza from Taking Cancer on Through Flavour is made
History video

History video

Learn more about the history of the innovative pharmaceutical company Boehringer Ingelheim
Where to meet us

Where to meet us

Find out where to meet the BD&L team virtually or in person at the next conference or event. Submit your opportunity to our BD&L team here.
Matthias Muenks

Matthias Muenks

Matthias Muenks, Global Engineering Process and Data Manager, speaks about our innovation and culture.
Labor & Human Rights

Labor & Human Rights

Suppliers shall support and respect the protection of internationally proclaimed human rights.
Vienna

Vienna

Vienna is a cornerstone within the company’s global R&D network, with a special focus on cancer research. On top of that, it is also a hub for biopharmaceutical development and production.
opening-solids-launch-fabrik

opening-solids-launch-fabrik

Boehringer Ingelheim today opened a tablet factory at Ingelheim in the presence of the State Premier of Rhineland-Palatinate, Malu Dreyer.